27 Stocks Moving in Thursday's Pre-Market Session

Gainers

  • Phunware, Inc. PHUN rose 25.8% to $4.09 in pre-market trading after surging around 12% on Wednesday.
  • Digital World Acquisition Corp. DWAC rose 25.4% to $55.61 in pre-market trading. Trump Media & Technology Group (TMTG), which is set to list in New York through a merger with Digital World Acquisition, is reportedly looking to raise up to $1 billion by selling shares to hedge funds and family offices.
  • Arbutus Biopharma Corporation ABUS rose 15.4% to $5.32 in pre-market trading. Arbutus Biopharma announced preliminary data from its Phase 1a/1b trial of AB-836, an oral hepatitis B virus (HBV) capsid inhibitor that interacts with HBV core protein, which in turn is required for viral replication.
  • Snowflake Inc. SNOW rose 15.3% to $358.62 in pre-market trading after the company reported better-than-expected Q3 sales results and issued guidance.
  • RLX Technology Inc. RLX rose 13.9% to $4.68 in pre-market trading after RLX Technology is expected to report Q3 financial results on December 3, 2021.
  • Remark Holdings, Inc. MARK rose 10% to $1.32 in pre-market trading after gaining 6% on Wednesday.
  • Sasol Limited SSL rose 10% to $18.05 in pre-market trading.
  • trivago N.V.  TRVG rose 9.2% to $2.25 in pre-market trading.
  • Humanigen, Inc. HGEN rose 8.8% to $6.06 in pre-market trading following an 8% drop on Wednesday.
  • Vir Biotechnology, Inc. VIR shares rose 8.6% to $51.00  in pre-market trading. GlaxoSmithKline and Vir Biotechnology announced an update to bioRxiv, a preprint server, with preclinical data for sotrovimab, COVID-19 targeting monoclonal antibody.
  • Meten Holding Group Ltd.  METX rose 7.4% to $0.3148 in pre-market trading after declining 15% on Wednesday.
  • ERYTECH Pharma S.A. ERYP rose 6.8% to $2.67 in pre-market trading after declining more than 8% on Wednesday.
  • Bakkt Holdings, Inc. BKKT rose 6.1% to $14.86 in pre-market trading after declining around 10% on Wednesday.
  • COMSovereign Holding Corp. COMS rose 6.1% to $1.04 in pre-market trading after dropping 9% on Wednesday.

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Tantech Holdings Ltd TANH fell 40.7% to $0.89 in pre-market trading after the company reported a proposed underwritten public offering of common shares.
  • MDJM Ltd MDJH shares fell 11.7% to $2.65 in pre-market trading after jumping 14% on Wednesday.
  • 180 Life Sciences Corp. ATNF fell 11.6% to $4.46 in pre-market trading after dipping more than 20% on Wednesday.
  • OceanPal Inc. OP shares fell 11.6% to $5.77 in pre-market trading. OceanPal shares gained 25% on Wednesday after completion of spinoff from Diana Shipping on Tuesday.
  • NLS Pharmaceutics AG NLSP fell 10% to $1.80 in pre-market trading..
  • Advanced Human Imaging Limited AHI shares fell 9.8% to $4.04 in pre-market trading. Advanced Human Imaging shares gained 44% on Wednesday as traders circulated a press release from the company titled 'Advanced Human Imaging concludes Definitive agreements with Canadian based Cubert.'
  • Cumberland Pharmaceuticals Inc. CPIX fell 9.8% to $3.70 in pre-market trading after dipping 18% on Wednesday. Cumberland Pharmaceuticals recently announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
  • Skylight Health Group Inc. SLHG fell 9.4% to $1.54 in pre-market trading after jumping over 28% on Wednesday.
  • Pasithea Therapeutics Corp. KTTA shares fell 8.8% to $3.01 in pre-market trading. Pasithea Therapeutics recently priced its 8.68 million share private placement at $3.50 per share.
  • Palatin Technologies, Inc. PTN fell 8.8% to $0.5201 in pre-market trading after tumbling 20% on Wednesday.
  • Katapult Holdings, Inc. KPLT fell 8.5% to $3.35 in pre-market trading. The Company booked Gross Originations from October 1, 2021, through November 30, 2021, of $40.4 million.
  • NuZee, Inc. NUZE shares fell 8.4% to $3.49 in pre-market trading after declining 18% on Wednesday.
  • VBI Vaccines Inc. VBIV shares fell 7.1% to $2.90 in pre-market trading. The FDA recently approved VBI Vaccines’ PreHevbrio [Hepatitis B Vaccine (Recombinant)] to prevent the infection caused by all known subtypes of hepatitis B virus (HBV) in adults age 18 years and older.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasCommunications EquipmentInformation TechnologyPre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!